Trastuzumab deruxtecan
Daiichi Sankyo,AstraZeneca
['t-dxd']
wrapping up this excellent session with dr. benjamin solomon telling the story of t-dm1 and t-dxd, driving home the importance of the linker and payload in adc efficacy. looking forward to exploring the basic science of adcs at dava's think tank in 2024. #asco23 
DAVA Oncology is a strategic consulting company that offers numerous products and services customized to fit biopharmaceutical drug development needs.